Piepszak Jennifer

JPM COO Piepszak sells 9,136 shares at $306.56; stock now $305.93 as sector digests rate outlook.

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase, sold 9,136 shares on April 15, 2026, at $306.56, reducing her stake by 9.2% to 90,001 shares and realizing $2,800,712.97. The sale occurred near the 52-week high of $334.61 (currently -8.6% below peak), though the stock has gained 6.9% over the prior 30 days. Her prior four measurable sales at JPM showed mixed timing outcomes: only 1 of 4 exhibited negative 90-day returns (well-timed sells), while others captured positive post-sale rallies—a 25% well-timed rate at this ticker. Cross-ticker, her six prior open-market sales averaged 90-day returns of +8.6% with a 20% well-timed rate, suggesting her overall sales timing has been inconsistent. JPMorgan's fundamentals remain solid with $46.4B quarterly revenue, $14.4B net income, and a 14.58 P/E, reducing downside risk from any single transaction.

JPM COO Jennifer Piepszak sold 8,571 shares at $312.79 on 2026-01-16 for $2.7M, reducing holdings to 71.0K shares.

Piepszak sold 8,571 shares at $312.79, with the stock currently priced at $312.47 (essentially flat from the transaction price). The sale reduced her holdings by 10.8% to 71.0K shares. Across her prior five sells at JPM, only 1 of 5 were well-timed at the 90-day mark, suggesting inconsistent timing on this ticker. Her cross-ticker track record shows an 8.6% average 90-day return after prior sells with a 20.0% well-timed rate, but this performance does not necessarily translate to JPM specifically. JPM trades at a P/E of 14.66 with strong recent fundamentals: $46.4B quarterly revenue, $14.4B net income, and 12.3% annual revenue growth. The sale itself is within the normal magnitude of executive portfolio adjustments and lacks a clear catalyst in current price action or valuation context.

JPM COO Jennifer Piepszak sold 6,128 shares at $262.47 on 2025-06-05 for $1,608,424.13; holds 62,455 shares post-transaction.

Jennifer Piepszak sold 6,128 shares representing an 8.9% reduction in her JPM holdings, reducing her position from 68,583 to 62,455 shares. Her prior trades at JPM show mixed timing outcomes: a 30-day return of +4.5% following her most recent sale on 2025-05-06 one month prior, but only 1 of 2 measurable prior sales had negative 90-day returns, indicating inconsistent timing on this ticker. Across her broader cross-ticker history, her 4 prior sells averaged a 90-day return of +0.1% with a 50% well-timed rate—suggesting her historical sales have slightly missed upward moves more often than they've preceded declines. JPM trades at a P/E of 12.20 with strong recent fundamentals: $45.3B quarterly revenue, $14.6B net income, and +12.3% annual revenue growth. The sale occurred near the stock's 52-week high ($279.95), with JPM currently down 6.4% from that peak.

JPM COO Jennifer Piepszak sells 6,129 shares at $250.76 for $1.5M; retains 68,583 shares

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase, sold 6,129 shares on 2025-05-06 at $250.76, reducing her holdings by 8.2% to 68,583 shares. The sale occurred near the 52-week high ($279.95), with JPM currently trading at $249.25, down 11.0% from that peak. Her same-ticker history shows one measurable prior sale (2024-05-08) with a positive 90-day return (+3.4%), indicating that particular sale was poorly-timed; her two more recent JPM sales (March and February 2025) have not yet shown 90-day outcomes. The company's fundamentals remain solid: $45.3B quarterly revenue, $14.6B net income, and a P/E of 11.60. This transaction represents a routine reduction in a substantial executive position, consistent with her documented pattern of periodic open-market sales across her tenure.

JPM COO Jennifer Piepszak sold 4,272 shares ($1.1M) at $247.03 on 2025-03-24.

Piepszak sold 4,272 shares (4.3K shares) for $1,055,314.30, reducing her holdings by 7.8% to 50,197 shares (50.2K shares). Her cross-ticker track record shows 2 prior sells with an average 90-day return of +3.4%, indicating that her previous sales were generally poorly-timed (stock rose after the sales). At JPM specifically, her prior sell on 2025-02-20 showed a 30-day decline of -10.5%, though longer-term outcomes remain unmeasurable. The current price of $248.06 is -6.1% below the transaction price over 30 days, positioning this sale closer to break-even territory relative to her cross-ticker history. With JPM trading at a P/E of 11.06 and posting quarterly net income of $12.9B on $42.7B revenue, the company remains fundamentally sound, but the recent stock weakness and the insider's concentrated equity position merit straightforward observation.

JPM COO Jennifer Piepszak sold 4,273 shares at $269.85 on 2025-02-20 for $1,153,078.02 total value.

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase, executed an open-market sale of 4,273 shares at $269.85, reducing her holdings from 58,742 shares to 54,469 shares (a 7.3% reduction). The stock is trading near its 52-week range at $266.80, down 4.7% from the 52-week high of $279.95, but up 1.4% over the past 30 days and 7.3% over 90 days. Against her cross-ticker track record of 1 prior sale with positive 90-day returns (avg 3.4%), the subsequent stock performance suggests prior sales have not been well-timed (90-day well-timed rate 0.00%), indicating her timing signals historically have not preceded declines. JPMorgan's fundamentals remain solid with annual revenue growth of 12.3% and a low P/E of 11.90, providing no signals of operational distress that would necessarily explain the sale.